A traditional Indian dietary approach called thali may help to lower chronic disease risk through its gut health benefits, according to a study led by Pennsylvania State University.
The supply of botanical materials for Ayurvedic preparations seems secure despite the growing popularity of the products and a recent report that some rules governing wild harvest are being flaunted.
Yakult Danone India is currently surveying two places — Panjab and Madhya Pradesh — for market expansion, MD Minoru Shimada told NutraIngredients-Asia.
Wattle Health is making significant headway in both India and China, starting with a 12-month deal with Vasudevan and Sons Exim Private (VSEP) for its baby food range.
Establishing tolerable upper limits (TUL) and allowing health claims based on regulations from overseas can help India's supplement sector 'self-regulate', and grow the market to US$10bn by 2025.
Nutrify India Now (NIN), a new diet-tracking phone application that seeks to tackle India's dual burdens of obesity and malnutrition, has been downloaded more than 10,000 times since its launch.
The Indian government has announced that 118 districts in the country will receive fortified rations, in its latest attempt to fight widespread malnutrition, especially among women and children.
The Food Safety and Standards Authority of India (FSSAI) has issued a notification detailing its updated directions for a list of ingredients it deems unsuitable for further use in health foods and supplements.
OmniActive Health Technologies believes its recent Good Manufacturing Practices (GMP) registration for its Hosur, Tamil Nadu facility is likely to strengthen its bid for APAC expansion.
Chr. Hansen is optimistic it can tap into the benefits of its patented probiotic strain, LGG, and growing consumer health consciousness to drive sales in India.
South Asia is in dire need of more sustainable vitamin A supplementation programming, with the region suffering from the world's second highest rate of vitamin A deficiency among children.
Indian pharmaceutical firm Sundyota Numandis will open a US$12m probiotic facility to meet demand, following link-ups with major industry players to develop and market a patented formulation.
